Opioid toxicity: Difference between revisions

(format)
Line 7: Line 7:


==Clinical Features==
==Clinical Features==
#Common
===Common===
##Miosis  
#Miosis  
##N/V
#N/V
##Respiratory depression
#Respiratory depression
##Mental status depression
#Mental status depression
#Uncommon
===Uncommon===
##QT prolongation (methadone)
#QT prolongation (methadone)
##Seizure (tramadol)
#Seizure (tramadol)
##Acute lung injury
#Acute lung injury
##Bowel obstruction, rupture (body packers)
#Bowel obstruction, rupture (body packers)
##Noncardiogenic pulmonary edema (1-2% of heroin overdoses)<ref>Sporer KA and Dorn E. Heroin-related noncardiogenic pulmonary edema: a case series. Chest. 2001; 120(5):1628-32.</ref>
#Noncardiogenic pulmonary edema (1-2% of heroin overdoses)<ref>Sporer KA and Dorn E. Heroin-related noncardiogenic pulmonary edema: a case series. Chest. 2001; 120(5):1628-32.</ref>
###Within 2-4 hrs of overdose
##Within 2-4 hrs of overdose
###Increased RR, cough, pink frothy sputum, CXR with b/l infiltrates
##Increased RR, cough, pink frothy sputum, CXR with b/l infiltrates
###Resolves in 24-48 hrs with respiratory supportive care
##Resolves in 24-48 hrs with respiratory supportive care


==Differential Diagnosis==
==Differential Diagnosis==

Revision as of 01:02, 13 April 2015

Background

  • Obtain acetaminophin levels in all cases of combination opioid-acetaminophen overdoses
  • Respiratory depression is the cause of all mortality from opioid toxicity
  • When prescribing opioid pain relievers in the ED, remember to have a discussion of co-ingestion of other depressants (alcohol involved in 1/5 of opioid related deaths)[1]
  • Consider contributing to the DAWN database for public ED research benefit (Drug Abuse Warning Network)
  • Other than common co-ingestions, consider adulterants such as amphetamines, anticholinergics, hypnotics, heavy metals, etc.

Clinical Features

Common

  1. Miosis
  2. N/V
  3. Respiratory depression
  4. Mental status depression

Uncommon

  1. QT prolongation (methadone)
  2. Seizure (tramadol)
  3. Acute lung injury
  4. Bowel obstruction, rupture (body packers)
  5. Noncardiogenic pulmonary edema (1-2% of heroin overdoses)[2]
    1. Within 2-4 hrs of overdose
    2. Increased RR, cough, pink frothy sputum, CXR with b/l infiltrates
    3. Resolves in 24-48 hrs with respiratory supportive care

Differential Diagnosis

Sedative/hypnotic toxicity

Treatment

  1. Airway protection and ventilatory management
    • BVM and naloxone administration may prevent need for intubation
  2. Naloxone (Narcan)
    • Bolus (May repeat q3min up to max dose 10mg
      • Apneic or near-apneic - 2mg IV
      • Opioid-naive with minimal respiratory depression - 0.4mg IV
      • Opioid-dependent with minimal respiratory depression - 0.05mg IV
      • Almost immediate onset of action
      • Duration of action = 20-90min (may be less than that of the ingested opioid)
    • Infusion
      • Only give if the pt responded to the bolus and required repeat administration
      • Step 1: Determine the "wake-up dose" or bolus required to wake the pt
      • Step 2: Give 2/3 of the "wake-up dose" per hr; mix in 1L D5W
  3. GI decontamination

Disposition

  1. Heroin intoxication:
    1. Consider discharge 1-2hr after naloxone administration if all are true:
      1. Independent mobility
      2. O2 sat >92% (room air)
      3. RR >10bpm
      4. HR >50
      5. Normal temp
      6. GCS 15
  2. Non-heroin intoxication:
    1. Consider discharge after 4-6hr obs
  3. Consider discharge with Rx for Naloxone
    • Naloxone 2 mg/2 mL prefilled syringe and intranasal atomizer device
      #2 each
      Spray one-half of syringe (1 mL) into each nostril upon signs of opioid overdose. May repeat X 1. Call 911.

See Also

External Links

Source

  1. Jones CM, Paulozzi LJ, Mack KA. Alcohol Involvement in Opioid Pain Reliever and Benzodiazepine Drug Abuse–Related Emergency Department Visits and Drug-Related Deaths — United States, 2010. CDC MMWR. October 10, 2014 / 63(40);881-885.
  2. Sporer KA and Dorn E. Heroin-related noncardiogenic pulmonary edema: a case series. Chest. 2001; 120(5):1628-32.